Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01011101 · ClinicalTrials.gov registry record

Internal Monitoring of Eye Movement in Schizophrenia

A clinical trial, sponsored by National Eye Institute (NEI).

Terminated
Registry status
2
Enrollment target

NCT01011101: Clinical Trial study, sponsored by National Eye Institute (NEI).

NCT01011101 is a clinical trial that was terminated before completion, run by National Eye Institute (NEI). The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01011101 was terminated before completion, sponsored by National Eye Institute (NEI).

TERMINATED
Registry status
2 participants
Enrollment target

Study Summary

Background: * Researchers are studying how humans are able to move our eyes to a remembered region even when the target has disappeared. The ability to do this suggests that the brain can keep track of where the eyes have looked, without an external target for continued reference. This is called corollary discharge. * Other research has indicated that patients with schizophrenia might have difficulty monitoring their eye movements. The corollary discharge process may be defective in patients with schizophrenia, and perhaps delayed in time. Researchers have developed a test to examine this possibility in the hope of learning more about schizophrenia and eye movement. Objectives: \- To assess whether there is a defect in internal monitoring of eye movements in patients with schizophrenia. Eligibility: * Individuals over 18 years of age who are able to give informed consent and are able to concentrate on a 20-minute task that involves following projected targets and moving their eyes to remembered locations. * Individuals with schizophrenia will be recruited from an ongoing NIH protocol studying schizophrenia. * In addition healthy will be recruited for this protocol. Design: * Researchers will check participants' vision in each eye, and ask them to sit at a machine that measures eye movement in order to complete research tasks. Researchers will monitor participants ability to complete these tasks. * The first task involves simply following a target that jumps to different parts of the screen. * The second is a 2-step task, in which a participant is asked to look at two separate light targets and then look at the remembered target positions when the lights are off. * This protocol does not provide treatment. Participants will remain under the care of their own physicians during participation in this protocol.

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2009-11-02
Est. Completion 2016-08-16
National Eye Institute (NEI)

221 total trials

Why NCT01011101 stopped before completion

NCT01011101 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01011101 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01011101 about?

NCT01011101 is a clinical study titled "Internal Monitoring of Eye Movement in Schizophrenia". Background: * Researchers are studying how humans are able to move our eyes to a remembered region even when the target has disappeared. The ability to do this suggests that the brain can keep track of where the eyes have looked, without an external target for continued reference. This is called co...

What is the current status of trial NCT01011101?

This trial is currently terminated. The enrollment target is 2 participants. The study started on 2009-11-02. Estimated completion is 2016-08-16.

Who is sponsoring clinical trial NCT01011101?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01011101, the US trial registry maintained by the National Library of Medicine. NCT01011101 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.